Medivation, a biopharmaceutical company, has received the FDA approval to begin a pivotal Phase III trial of MDV3100, its novel androgen receptor antagonist, in patients with metastatic castration-resistant
Genzyme, a biotechnology company, has announced that the European Medicines Agency’s Committee for Human Medicinal Products has adopted a positive opinion for the marketing authorization of the new
Joining Medtronic are Ardian’s three existing investors: Advanced Technology Ventures, Morgenthaler Ventures and Split Rock Partners, as well as new investor Emergent Medical Partners. Andrew Cleeland, president and
Under the agreement, clinical laboratory customers around the world continue to have access to the largest portfolio of coagulation instruments and tests. The companies will also continue joint
BioDuro will provide integrated research services in the areas of discovery chemistry, discovery biology, ADMET, and DMPK services, to help enhance internal drug discovery and shorten development timelines.
The study is a randomized, double-blind, placebo-controlled study in approximately 140 patients to evaluate the safety, tolerability and efficacy of daily TT-223 treatments in combination with weekly administrations
BioMarin Pharmaceutical has reported that its clinical trial application, or CTA, for BMN 110 or N-acetylgalactosamine 6-sulfatase, intended for the treatment of the lysosomal storage disorder mucopolysaccharidosis type
According to the company, the Therakos Cellex photopheresis system is an easy-to-use, integrated system that uses extracorporeal photopheresis, a cellular therapy, to relieve the symptoms of cutaneous T-cell
The new company, headquartered in Deerfield, Illinois, will focus on acquiring and operating specialty pharmaceutical companies and products. Target opportunities include products which are already approved or currently
ACell’s MatriStem regenerative medicine technology is a naturally occurring bioscaffold derived from porcine tissue. When MatriStem is placed onto a wound, it is resorbed and replaced with new
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.